John S. Montalbano is Director of AbCellera Biologics Inc.. Currently has a direct ownership of 86,000 shares of ABCL, which is worth approximately $234,780. The most recent transaction as insider was on Nov 08, 2023, when has been sold 10,000 shares (Common Shares) at a price of $4.46 per share, resulting in proceeds of $44,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 86K
0% 3M change
53.57% 12M change
Total Value Held $234,780

John S. Montalbano Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 08 2023
BUY
Open market or private purchase
$44,600 $4.46 p/Share
10,000 Added 10.42%
86,000 Common Shares
Nov 06 2023
BUY
Open market or private purchase
$92,800 $4.64 p/Share
20,000 Added 20.83%
76,000 Common Shares
Mar 04 2022
BUY
Open market or private purchase
$85,400 $8.54 p/Share
10,000 Added 15.15%
56,000 Common Shares
Mar 01 2022
BUY
Open market or private purchase
$181,000 $9.05 p/Share
20,000 Added 30.3%
46,000 Common Shares
Aug 16 2021
BUY
Open market or private purchase
$103,380 $17.23 p/Share
6,000 Added 18.75%
26,000 Common Shares
Dec 15 2020
BUY
Open market or private purchase
$400,000 $20.0 p/Share
20,000 Added 50.0%
20,000 Common Shares
JSM

John S. Montalbano

Director
Vancouver, A1

Track Institutional and Insider Activities on ABCL

Follow AbCellera Biologics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABCL shares.

Notify only if

Insider Trading

Get notified when an Ab Cellera Biologics Inc. insider buys or sells ABCL shares.

Notify only if

News

Receive news related to AbCellera Biologics Inc.

Track Activities on ABCL